Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
VYGR

Voyager Therapeutics

$8.27

-0.22 (-2.59%)

, RHHBY

Roche

$0.00

(0.00%)

07:07
01/22/19
01/22
07:07
01/22/19
07:07
Hot Stocks
Voyager Therapeutics names Robert Hesslein as general counsel »

Voyager Therapeutics…

VYGR

Voyager Therapeutics

$8.27

-0.22 (-2.59%)

RHHBY

Roche

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jan

  • 01

    Feb

  • 18

    Mar

Over a week ago
VYGR

Voyager Therapeutics

$8.93

-0.16 (-1.76%)

, RHHBY

Roche

$0.00

(0.00%)

07:28
01/15/19
01/15
07:28
01/15/19
07:28
Hot Stocks
Voyager Therapeutics appoints Omar Khwaja as CMO »

Voyager Therapeutics…

VYGR

Voyager Therapeutics

$8.93

-0.16 (-1.76%)

RHHBY

Roche

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jan

  • 01

    Feb

  • 18

    Mar

VYGR

Voyager Therapeutics

$9.34

-0.12 (-1.27%)

09:06
01/08/19
01/08
09:06
01/08/19
09:06
Recommendations
Voyager Therapeutics analyst commentary at BTIG »

Voyager Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VYGR

Voyager Therapeutics

$9.46

0.55 (6.17%)

07:11
01/07/19
01/07
07:11
01/07/19
07:11
Hot Stocks
Voyager says to increase size of RESTORE-1 Phase 2 trial following FDA feedback »

Voyager Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a month ago
VYGR

Voyager Therapeutics

$10.82

0.2 (1.88%)

07:26
12/10/18
12/10
07:26
12/10/18
07:26
Hot Stocks
Voyager Therapeutics doses first patient in RESTORE-1 trial »

Voyager Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VYGR

Voyager Therapeutics

$11.67

0.44 (3.92%)

07:05
11/29/18
11/29
07:05
11/29/18
07:05
Hot Stocks
Voyager enters into collaborations with Brammer Bio, Fujifilm Diosynth »

Voyager Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VYGR

Voyager Therapeutics

$11.67

0.44 (3.92%)

, JAZZ

Jazz Pharmaceuticals

$146.22

-3.81 (-2.54%)

04:55
11/29/18
11/29
04:55
11/29/18
04:55
Conference/Events
Evercore ISI to hold a conference »

Evercore ISI HEALTHConx…

VYGR

Voyager Therapeutics

$11.67

0.44 (3.92%)

JAZZ

Jazz Pharmaceuticals

$146.22

-3.81 (-2.54%)

ALXN

Alexion

$122.91

2.01 (1.66%)

IMGN

ImmunoGen

$5.63

0.37 (7.03%)

DOVA

Dova Pharmaceuticals

$15.29

0.16 (1.06%)

PRQR

ProQR Therapeutics

$19.00

-0.06 (-0.31%)

HRTX

Heron Therapeutics

$28.40

1.95 (7.37%)

BOLD

Audentes Therapeutics

$24.30

0.81 (3.45%)

CDNA

CareDx

$28.52

1.02 (3.71%)

PKI

PerkinElmer

$85.87

2.965 (3.58%)

ALNY

Alnylam

$78.02

(0.00%)

CVS

CVS Health

$80.33

0.78 (0.98%)

CBAY

CymaBay

$9.12

0.4 (4.59%)

CNC

Centene

$140.84

4.76 (3.50%)

TOCA

Tocagen

$12.09

0.56 (4.86%)

AMGN

Amgen

$201.43

4.25 (2.16%)

NERV

Minerva

$8.27

0.35 (4.42%)

TBIO

Translate Bio

$7.37

0.69 (10.33%)

RCUS

Arcus Biosciences

$11.55

0.64 (5.87%)

TXMD

TherapeuticsMD

$5.08

0.22 (4.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

  • 29

    Nov

  • 01

    Dec

  • 02

    Dec

  • 03

    Dec

  • 03

    Dec

  • 05

    Dec

  • 12

    Dec

  • 14

    Dec

  • 20

    Dec

  • 18

    Feb

  • 30

    Jun

VYGR

Voyager Therapeutics

$12.04

0.2 (1.69%)

, JAZZ

Jazz Pharmaceuticals

$151.06

1.11 (0.74%)

16:33
11/26/18
11/26
16:33
11/26/18
16:33
Conference/Events
Evercore ISI to hold a conference »

Evercore ISI HEALTHConx…

VYGR

Voyager Therapeutics

$12.04

0.2 (1.69%)

JAZZ

Jazz Pharmaceuticals

$151.06

1.11 (0.74%)

ALXN

Alexion

$119.02

0.94 (0.80%)

IMGN

ImmunoGen

$5.73

0.23 (4.18%)

DOVA

Dova Pharmaceuticals

$15.05

-0.2 (-1.31%)

PRQR

ProQR Therapeutics

$19.11

-0.39 (-2.00%)

HRTX

Heron Therapeutics

$25.96

-0.065 (-0.25%)

BOLD

Audentes Therapeutics

$24.41

0.5 (2.09%)

CDNA

CareDx

$27.73

0.43 (1.58%)

PKI

PerkinElmer

$82.84

1.15 (1.41%)

ALNY

Alnylam

$78.49

5 (6.80%)

CVS

CVS Health

$77.83

2.3451 (3.11%)

CBAY

CymaBay

$9.00

-0.31 (-3.33%)

CNC

Centene

$138.46

2.23 (1.64%)

TOCA

Tocagen

$11.65

0.28 (2.46%)

AMGN

Amgen

$194.31

2.06 (1.07%)

NERV

Minerva

$8.67

-0.16 (-1.81%)

TBIO

Translate Bio

$6.86

-0.09 (-1.30%)

RCUS

Arcus Biosciences

$11.24

-0.37 (-3.19%)

TXMD

TherapeuticsMD

$4.85

-0.05 (-1.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 27

    Nov

  • 29

    Nov

  • 01

    Dec

  • 02

    Dec

  • 03

    Dec

  • 03

    Dec

  • 05

    Dec

  • 12

    Dec

  • 14

    Dec

  • 20

    Dec

  • 18

    Feb

  • 30

    Jun

MYL

Mylan

$34.35

0.12 (0.35%)

, COPY

CopyTele

$0.00

(0.00%)

10:24
11/15/18
11/15
10:24
11/15/18
10:24
Upgrade
On The Fly: Top five analyst upgrades »

Catch up on today's…

MYL

Mylan

$34.35

0.12 (0.35%)

COPY

CopyTele

$0.00

(0.00%)

VYGR

Voyager Therapeutics

$12.07

0.82 (7.29%)

ATNX

Athenex

$10.97

0.69 (6.71%)

COTY

Coty

$8.88

0.18 (2.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 03

    Mar

VYGR

Voyager Therapeutics

$11.25

-0.54 (-4.58%)

19:49
11/14/18
11/14
19:49
11/14/18
19:49
Upgrade
Voyager Therapeutics rating change at Raymond James »

Voyager Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.